BTK-IN-45 (Compound 6b) is a potent, reversible, and selective BTK inhibitor with an IC 50 of 1.14 μM. BTK-IN-45 also exhibits modest inhibition for LCK . BTK-IN-45 can be used in the research of cancers, including leukemia.
Products | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer | Products > Signaling Pathways > Btk | Products > Signaling Pathways > Src
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。